Provided by Tiger Trade Technology Pte. Ltd.

AxoGen

41.85
-5.4200-11.47%
Post-market: 42.050.2000+0.48%19:49 EDT
Volume:3.79M
Turnover:163.33M
Market Cap:2.25B
PE:-61.79
High:45.50
Open:45.14
Low:41.74
Close:47.27
52wk High:52.91
52wk Low:15.27
Shares:53.66M
Float Shares:52.65M
Volume Ratio:5.33
T/O Rate:7.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6773
EPS(LYR):-0.3410
ROE:-18.21%
ROA:-3.15%
PB:8.76
PE(LYR):-122.73

Loading ...

Axogen Down over 10%, on Pace for Largest Percent Decrease Since May 2025

Dow Jones
·
12 hours ago

Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Thursday Amid Producer Price Inflation Data Release

MT Newswires Live
·
Yesterday

U.S. Stocks on the MOVE-Lovesac, Hagerty, Biohaven

Reuters
·
Yesterday

U.S. Stocks on the MOVE-AeroVironment, Macy's, Navan

Reuters
·
Yesterday

Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies

Reuters
·
Yesterday

Axogen Drops After Equity Raise for $200 Mln BioCircuit Acquisition

Reuters
·
Yesterday

Axogen Prices $208.7 Million Public Offering

MT Newswires Live
·
Yesterday

AxoGen to Acquire BioCircuit, Expanding Nerve Repair Portfolio

TIPRANKS
·
Yesterday

AxoGen Shares Down 5% Premarket After Announcing Public Offering of $208.7 Mln at Discounted Price of $42.5 Per Share; Co to Buy Biocircuit for $200 Mln

THOMSON REUTERS
·
Yesterday

Axogen to Buy NerveTape Maker BioCircuit for $200 Million

Dow Jones
·
Yesterday

Axogen Prices 4,910,000-Share Follow-on Offering at USD 42.5 Per Share

Reuters
·
Yesterday

AxoGen Announces Pricing of $208.7 Million Public Offering of Common Stock

THOMSON REUTERS
·
Yesterday

AxoGen, - AxoGen Prices Public Offering of 4,910,000 Shares at $42.50 Per Share

THOMSON REUTERS
·
Yesterday

Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock

GlobeNewswire
·
Yesterday

AxoGen, - AxoGen to Buy Biocircuit for $200 Mln in Cash

THOMSON REUTERS
·
Yesterday

AxoGen, - AxoGen to Fund Purchase Price with Net Proceeds from Public Offering

THOMSON REUTERS
·
Yesterday

AxoGen, - Deal Expected to be Accretive to Revenue, Adj Ebitda Margin and Adj EPS in First Year

THOMSON REUTERS
·
Yesterday

AxoGen Enters into Definitive Agreement to Acquire Biocircuit Technologies

THOMSON REUTERS
·
Yesterday

Axogen Director Joseph A. Tyndall Disposes of Common Shares Worth $173,939.50

Reuters
·
Sep 05

Axogen Management to Hold One-on-One Investor Meetings at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 01